VolitionRx Limited announced that it will receive $100,000 in funding on March 12, 2024. The company will issue common shares in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.72 USD | -0.98% | +5.88% | +0.42% |
May. 14 | Transcript : VolitionRx Limited, Q1 2024 Earnings Call, May 14, 2024 | |
May. 13 | VolitionRx Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.42% | 59.63M | |
-41.39% | 8.02B | |
+3.25% | 3.43B | |
-0.37% | 2.27B | |
-19.19% | 2.03B | |
-22.57% | 1.63B | |
+32.82% | 1.16B | |
-8.30% | 703M | |
+14.12% | 714M | |
-31.22% | 500M |
- Stock Market
- Equities
- VNRX Stock
- News VolitionRx Limited
- VolitionRx Limited announced that it expects to receive $0.1 million in funding